PROCESSA PHARMACEUTICALS INC PCSA
$2.16
+10.2% 52w: $1.85 – $11.97
Latest 13F among current holders filed 1 month ago (May 15, 2026)
Price — last 12 months
research preview data1.856.9111.97
Jun 20, 2025 Jul 2, 2026
Institutional holders
10
+0 QoQ
13F value
$448K
+35.5% QoQ
Smart-money holders
1
signal tier ≥ 2
New smart buyers
0
Q1 2026
Institutional value by quarter
Number of holders
Who owns PCSA?
Q1 2026 filings| Fund | Type | Shares | Value | % of fund | Change |
|---|---|---|---|---|---|
| Connective Capital Management, LLC | Other | 70.7K | $179K | — | New |
| Stonepine Capital Management, LLC ★2 | Fundamental concentrated | 55.0K | $139K | — | +346.3% |
| GEODE CAPITAL MANAGEMENT, LLC | Index provider | 24.9K | $63K | — | +62.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | Diversified mechanical | 12.7K | $32K | — | — |
| VANGUARD FIDUCIARY TRUST CO | Diversified mechanical | 10.9K | $27K | — | — |
| UBS Group AG | Bank broker | 2.5K | $6K | — | -80.0% |
| Tower Research Capital LLC (TRC) | Market maker | 918 | $2K | — | -34.0% |
| CITIGROUP INC | Bank broker | 14 | $35 | — | New |
| JONES FINANCIAL COMPANIES LLLP | Wealth advisor | 7 | $17 | — | Held |
| WELLS FARGO & COMPANY/MN | Bank broker | 6 | $15 | — | Held |
Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.
Explore related
Top funds holding PCSA
More healthcare stocks held by institutions